FIELD: medicine.
SUBSTANCE: invention relates to compounds of the formula I in a free or pharmaceutically acceptable salt form, as well as to their pharmaceutical compositions and methods for use in the treatment of diseases.
EFFECT: new prodrugs of substituted heterocyclic condensed gamma-carbolines of the formula I are obtained, which can be used for the treatment or prevention of a disorder of the central nervous system, where the disorder is a disorder including serotonin 5-HT2A, serotonin reuptake transporter (SERT), dopamine D1 and/or D2 path, and/or μ-opioid receptor.
15 cl, 19 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2776800C2 |
| ENANTIOMERICALLY PURE OPIOID DIARYLMETHYL PIPERAZINE AND METHODS FOR USES THEREOF | 2002 |
|
RU2309153C2 |
| USE OF SIGMA LIGANDS WITH INDUCED OPIOIDS HYPERALGESIA | 2011 |
|
RU2589899C2 |
| NEUROGENESIS MEDIATED WITH 4-ACYLAMINOPYRIDINE DERIVATIVES | 2007 |
|
RU2451512C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| SYNTHETIC PEPTIDE AMIDES | 2007 |
|
RU2500685C2 |
| ORGANIC COMPOUNDS | 2019 |
|
RU2809023C2 |
| ORGANIC COMPOUNDS | 2011 |
|
RU2591194C2 |
